GlassScriptPhysician profile
Heather A Rozencwaig
NPI 1043478100
$2,465.57
in general payments reported to CMS, 2019-2025
17 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $313 · 2023: $197 · 2024: $625 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949 · Travel and Lodging: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.97 |
| Travel and Lodging | $919.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,534.29 | 2024-2025 | Inspire |
| Optinose US, INC. | $202.95 | 2021-2024 | |
| Glaxosmithkline, LLC. | $151.57 | 2022-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $124.63 | 2022 | |
| Genzyme Corporation | $69.30 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.52 | 2023 | Cuvitru, Hyqvia |
| Alk-Abello, INC | $49.55 | 2021-2022 | |
| Kaleo, INC. | $44.97 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $44.93 | 2021-2022 | |
| Csl Behring | $44.77 | 2021-2022 | |
| Covis Pharma Gmbh | $35.80 | 2021 | |
| Stryker Corporation | $25.95 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.99 | 2025 | Cobenfy |
| Lilly USA, LLC | $18.75 | 2025 | Zepbound |
| Cook Medical LLC | $15.37 | 2025 | Rosen |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $13.83 | 2023 | Ryaltris |
| Merck Sharp & Dohme LLC | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rozencwaig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.